IRX-4204

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameIRX-4204
Drug Alias NameIRX-4204NRX-4204VTP-194204NRX-194204AGN-194204 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonistsNuclear receptor subfamily 4 group A member 2 agonists
TargetsRetinoid X receptorNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsPlaque psoriasisPsoriasisParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIo Therapeutics IncNurx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasisParkinson Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A